Olivia Briceño

Olivia Briceño

Auto-generated profile, based on publicly available information

Olivia Briceño

Infectious Diseases Research Center (CIENI), Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2024 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
IOIván Armando Osuna-Padilla
Iván Armando Osuna-Padilla
NRNadia Carolina Rodríguez-Moguel
Nadia Carolina Rodríguez-Moguel
AAAdriana Aguilar-Vargas
Adriana Aguilar-Vargas
MTMaricruz Tolentino-Dolores
Maricruz Tolentino-Dolores
OPOtilia Perichart-Perera
Otilia Perichart-Perera
DADafn
Dafn
Background and aim: Deficiency of zinc and selenium is common in persons living with human immunodeficiency virus (PLWHIV) and has been associated with the development of non-AIDS related comorbidities, impaired immune system function and mortality. Micronutrient supplementation on long-term-treated PLWHIV could bring potential clinical and immunological benefits improving their health status and quality of life. The aim of the present study is to analyze the effect of zinc and selenium supplementation on body composition, bone mineral density, CD4+ T-cell counts, metabolic profile and immune system status on clinical stable PLWHIV on long-term antiretroviral therapy (ART).Methods: This is a randomized pilot clinical trial in which we recruited 60 PLWHIV on ART who were assigned to the intervention groups: zinc (30 mg of zinc gluconate), selenium (200 μg of selenium yeast), zinc + selenium (same doses and presentations) or to a control group (without nutritional supplementation) who received supplementation during 6 months. Primary outcome was defined as changes in body composition (weight, muscle and fat mass and bone mineral density) and secondary outcomes as changes in biochemical and immunological parameters (CD4+ T-cell count, cholesterol, glucose, triglycerides and seric zinc and selenium seric concentrations) before and after supplementation. Peripheral blood mononuclear cells (PBMCs) of one individual of each intervention group were analyzed for single cell transcriptomics before and after supplementation.Results: BMI (p = 0.03), fat mass (p = 0.03), and trunk fat (p = 0.01) decreased after 6 months of selenium supplementation. No changes were observed for cholesterol, glucose or triglycerides after supplementation (p > 0.05 in all cases). CD4+ T cells percentage increased after 6 months of selenium supplementation (p = 0.03). On the transcriptome analysis, zinc and selenium supplementation induced changes on de expression of genes associated with the function of naive and memory CD8+ T-cells (p < 0.05 in all cases).Conclusion: Zinc and selenium supplementation could represent a complementary intervention that may improve the health status and immune response of treated PLWHIV.

1 July 2021 in Immunology Letters
Verified
Journal Article
Closed access
OBOlivia Briceño
Olivia Briceño
APAmy Peralta-Prado
Amy Peralta-Prado
DGDaniela Garrido-Rodríguez
Daniela Garrido-Rodríguez
KRKarla Romero-Mora
Karla Romero-Mora
MCMonserrat Chávez-Torres
Monserrat Chávez-Torres
SÁSantiago Ávila-Ríos
Santiago Ávila-Ríos

3 March 2023 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
OBOlivia Briceño
Olivia Briceño
APAmy Peralta-Prado
Amy Peralta-Prado
DGDaniela Garrido-Rodríguez
Daniela Garrido-Rodríguez
KRKarla Romero-Mora
Karla Romero-Mora
MCMonserrat Chávez-Torres
Monserrat Chávez-Torres
SÁSantiago Ávila-Ríos
Santiago Ávila-Ríos
Double-negative (DN) T cells represent a small and phenotypically heterogeneous population that display regulatory functions. In HIV infection, DN T cells are decreased in peripheral blood and have been negatively associated with T cell activation. This study was aimed at describing the dynamics and phenotypic characteristics of DN T cells in peripheral blood of people living with HIV (PLHIV) before and after antiretroviral therapy (ART) initiation. We included 41 newly diagnosed, ART-naive individuals with advanced HIV infection, who were followed up for 6 months after ART initiation. The control group included 34 people without HIV (PWHIV), on preexposure prophylaxis for HIV infection. DN T cells in peripheral blood were characterized by flow cytometry. The absolute counts of DN T cells were lower in PLHIV than in PWHIV ( p = 0.0223), and were particularly low in individuals with advanced HIV disease ( p = 0.0311). Activation of DN T cells before ART initiation was directly associated with viral load (VL) ( p = 0.0081, r = 0.4083) and inversely associated with CD4 + T cell counts ( p = 0.0004, r = −0.4041). Compared with PWHIV, DN T cells of PLHIV expressed higher levels of CD57 ( p = 0.0019), Ki67 ( p = 0.0065), PD-1 ( p = 0.0187), and CD38/HLA-DR ( p < 0.0001). After 6 months on ART, expression of Ki67, PD-1, and CD38/HLA-DR on DN T cells returned to similar levels to those observed in PWHIV ( p > 0.05 in all cases). However, expression of CD57 decreased only in individuals that start ART with high VL ( p = 0.0127). DN T cell counts are decreased in HIV infection. Low DN T cell counts remained despite ART-induced immune reconstitution and viremia control. DN T cell phenotype is altered during chronic untreated infection with a high proportion of proliferating, activated, exhausted, and senescent cells. Most markers return to levels similar to those observed in PWHIV after ART. The impact of altered phenotype of DN T and their regulatory functions warrants further exploration.

25 April 2025 in Nutrition
Verified
Journal Article
Closed access
EBEdgar Barrientos-Galeana
Edgar Barrientos-Galeana
NRNadia Carolina Rodríguez-Moguel
Nadia Carolina Rodríguez-Moguel
SÁSantiago Ávila-Ríos
Santiago Ávila-Ríos
IOIvan Armando Osuna-Padilla
Ivan Armando Osuna-Padilla
OBOlivia Briceño
Olivia Briceño

1 February 2022 in Nutrition
Verified
Journal Article
Closed access
IOIvan A. Osuna-Padilla
Ivan A. Osuna-Padilla
NRNADIA RODRIGUEZ
NADIA RODRIGUEZ
AAAdriana Aguilar-Vargas
Adriana Aguilar-Vargas
EREdna Rodríguez-Aguirre
Edna Rodríguez-Aguirre
OBOlivia Briceño
Olivia Briceño
SÁSantiago Ávila-Ríos
Santiago Ávila-Ríos

18 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
OBOlivia Briceño
Olivia Briceño
IGIris Guzmán-Guzmán
Iris Guzmán-Guzmán
Malen Massot-CladeraMalen Massot-Cladera
Malen Massot-Cladera
Infographic illustrating three columns: challenges such as thymic involution, cellular senescence, and epigenetic aging; targeted interventions including exercise, gut health, and mind-body therapies; and therapeutic outcomes like improved inflammatory balance, immune rejuvenation, and enhanced resilience.